Actively Recruiting
Evaluation of the CONVIVO System
Led by Dartmouth-Hitchcock Medical Center · Updated on 2026-02-06
30
Participants Needed
1
Research Sites
222 weeks
Total Duration
On this page
Sponsors
D
Dartmouth-Hitchcock Medical Center
Lead Sponsor
C
Carl Zeiss Meditec, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this study is to evaluate the diagnostic performance of the CONVIVO confocal endomicroscope in discriminating between normal and abnormal tissue in vivo during brain tumor surgery. The interpretation of intraoperative images obtained in situ will be tested against conventional histologic evaluation of targeted biopsies from imaged tissue. The study team hypothesize that there will be a high degree of correlation between images obtained with the CONVIVO system and conventional histologic interpretation.
CONDITIONS
Official Title
Evaluation of the CONVIVO System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (age >18)
- Adults with suspected intracranial gliomas (including glioblastoma), cerebral metastasis, meningiomas, acoustic neuromas, or pituitary adenomas
- Adults who are surgical candidates
- Adults able to provide informed consent
You will not qualify if you...
- Pregnancy
- Children under 18 years old
- Allergy to fluorescein sodium (FNa)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Actively Recruiting
Research Team
L
Linton T Evans, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here